TickerFactsScreenerDevelopers

Inhibitor Therapeutics, Inc. (INTI) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$369.1K2012: -$132.8K2013: -$765.8K2014: $62.1K2015: $424.0K2016: $7.03M2017: $166.6K2018: $32.4K2019: -$2.53M2020: -$3.36M2021: -$3.62M2022: $8.30M2023: $5.28M2024: $1.99M2025: -$1.29M-$1.29M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$1.29M-165.1%
2024$1.99M-62.4%
2023$5.28M-36.3%
2022$8.30M+329.1%
2021-$3.62M-7.8%
2020-$3.36M-32.8%
2019-$2.53M-7924.0%
2018$32.4K-80.6%
2017$166.6K-97.6%
2016$7.03M+1558.1%
2015$424.0K+583.0%
2014$62.1K+108.1%
2013-$765.8K-476.8%
2012-$132.8K+64.0%
2011-$369.1K—